FDA approves Arbel Medical's cryotherapy device

01/2/2008 | Globes (Israel)

The FDA has given its general approval for Arbel Medical to market its IceSense probe, a minimally invasive cryotherapy device for the removal of benign and malignant tumors. The Israel-based company plans to launch the product in 2009 and to seek specific approvals to use the device in removing breast and uterine tumors.

View Full Article in:

Globes (Israel)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY